AAAAAA
Results: 1-25/132
Authors:
KLINGEBIEL T
BADER P
BARES R
BECK J
HERO B
JURGENS H
LANG P
NIETHAMMER D
RATH B
HANDGRETINGER R
Citation: T. Klingebiel et al., TREATMENT OF NEUROBLASTOMA STAGE 4 WITH I-131 META-IODO-BENZYLGUANIDINE, HIGH-DOSE CHEMOTHERAPY AND IMMUNOTHERAPY - A PILOT-STUDY, European journal of cancer, 34(9), 1998, pp. 1398-1402
Authors:
SILIES H
BLASCHKE G
HOHENLOCHTER B
ROSSI R
JURGENS H
BOOS J
Citation: H. Silies et al., EXCRETION KINETICS OF IFOSFAMIDE SIDE-CHAIN METABOLITES IN CHILDREN ON CONTINUOUS AND SHORT-TERM INFUSION, International journal of clinical pharmacology and therapeutics, 36(5), 1998, pp. 246-252
Authors:
KARTHAUS M
EGERER G
KULLMANN KH
RITTER J
JURGENS H
Citation: M. Karthaus et al., CEFTRIAXONE IN THE OUTPATIENT TREATMENT OF CANCER-PATIENTS WITH FEVERAND NEUTROPENIA, European journal of clinical microbiology & infectious diseases, 17(7), 1998, pp. 501-504
Authors:
FUCHS N
BIELACK SS
EPLER D
BIELING P
DELLING G
KORHOLZ D
GRAF N
HEISE U
JURGENS H
KOTZ R
SALZERKUNTSCHIK M
WEINEL P
WERNER M
WINKLER K
Citation: N. Fuchs et al., LONG-TERM RESULTS OF THE COOPERATIVE GERMAN-AUSTRIAN-SWISS OSTEOSARCOMA STUDY-GROUPS PROTOCOL COSS-86 OF INTENSIVE MULTIDRUG CHEMOTHERAPY AND SURGERY FOR OSTEOSARCOMA OF THE LIMBS, Annals of oncology, 9(8), 1998, pp. 893-899
Authors:
KARTHAUS M
WOLF HH
EGERER G
KAMPFE D
HOFFKNECHT M
JURGENS H
Citation: M. Karthaus et al., CEFTRIAXONE MONOTHERAPY IN THE TREATMENT OF 376 EPISODES WITH LOW-RISK FEBRILE NEUTROPENIA, Annals of oncology, 9, 1998, pp. 678-678
Authors:
PAULUSSEN M
AHRENS S
BURDACH S
CRAFT A
DOCKHORNDWORNICZAK B
DUNST J
FROHLICH B
WINKELMANN W
ZOUBEK A
JURGENS H
Citation: M. Paulussen et al., PRIMARY METASTATIC (STAGE-IV) EWING TUMOR - SURVIVAL ANALYSIS OF 171 PATIENTS FROM THE EICESS STUDIES, Annals of oncology, 9(3), 1998, pp. 275-281
Authors:
DOCKHORNDWORNICZAK B
BRINKSCHMIDT C
POREMBA C
SCHAFER KL
JURGENS H
BOCKER W
Citation: B. Dockhorndworniczak et al., CHROMOSOME-11 ALTERATIONS - A COMMON MECHANISM IN TUMORIGENESIS OF RHABDOMYOSARCOMAS, Modern pathology, 11(1), 1998, pp. 8-8
Authors:
PAULUSSEN M
AHRENS S
CRAFT AW
DUNST J
FROHLICH B
JABAR S
RUBE C
WINKELMANN W
WISSING S
ZOUBEK A
JURGENS H
Citation: M. Paulussen et al., EWINGS TUMORS WITH PRIMARY LUNG METASTASES - SURVIVAL ANALYSIS OF 114(EUROPEAN INTERGROUP) COOPERATIVE EWINGS-SARCOMA STUDIES PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 3044-3052
Authors:
KARTHAUS M
WOLF HH
EGERER G
KAMPFE D
SUEDHOFF T
RITTER J
JURGENS H
Citation: M. Karthaus et al., CEFTRIAXONE IN THE TREATMENT OF SOLID TUMOR PATIENTS WITH FEBRILE NEUTROPENIA, Onkologie, 21(3), 1998, pp. 212-216
Authors:
DUNST J
AHRENS S
PAULUSSEN M
RUBE C
WINKELMANN W
ZOUBEK A
HARMS D
JURGENS H
Citation: J. Dunst et al., 2ND MALIGNANCIES AFTER TREATMENT FOR EWINGS-SARCOMA - A REPORT OF THECESS-STUDIES, International journal of radiation oncology, biology, physics, 42(2), 1998, pp. 379-384
Authors:
POLLMANN H
RICHTER H
JURGENS H
Citation: H. Pollmann et al., PLATELET DYSFUNCTION AS THE CAUSE OF SPONTANEOUS BLEEDING IN 2 HEMOPHILIC PATIENTS TAKING HIV PROTEASE INHIBITORS, Thrombosis and haemostasis, 79(6), 1998, pp. 1213-1214
Authors:
KOSCH A
MOLENKAMP G
DAUMLING E
DIRKSEN A
JURGENS H
WOLFF J
Citation: A. Kosch et al., ASSESSMENT OF INDEPENDENCE IN DAILY-LIFE IN PEDIATRIC ONCOLOGY BY FMH-QUESTIONAIRE, Klinische Padiatrie, 210(6), 1998, pp. 390-394
Authors:
TILLMANN B
KRUMPELMANN S
WURTHWEIN G
WAGNER A
SCHULZEWESTHOFF P
HEMPEL G
JURGENS H
BOOS J
Citation: B. Tillmann et al., PHARMACOKINETIC ASPECTS OF ORAL ETOPOSIDE, Klinische Padiatrie, 210(4), 1998, pp. 159-164
Authors:
WOLFF JEA
HUETTERMANN U
RITTER J
STRAETER R
PALM D
RUEBE C
KRAEHLING KH
JURGENS H
Citation: Jea. Wolff et al., MEDULLOBLASTOMA - EXPERIENCE OF A SINGLE INSTITUTION, Klinische Padiatrie, 210(4), 1998, pp. 234-238
Authors:
MOLENKAMP G
RIEMANN B
KUWERT T
STRATER R
KURLEMANN G
SCHOBER O
JURGENS H
WOLFF JEA
Citation: G. Molenkamp et al., MONITORING TUMOR-ACTIVITY IN LOW-GRADE GLIOMA OF CHILDHOOD, Klinische Padiatrie, 210(4), 1998, pp. 239-242
Authors:
PAPE H
BURDACH S
LAWS J
VANKAICK B
BANNACH B
SCHMITT G
GADNER H
JURGENS H
Citation: H. Pape et al., HIGH-DOSE-THERAPY, STEM-CELL RESCUE AND RADIOTHERAPY IN ADVANCE EWINGTUMORS, Bone marrow transplantation, 21, 1998, pp. 764-764
Authors:
WOLFF JEA
HAUCH H
KUHL J
EGELER M
JURGENS H
Citation: Jea. Wolff et al., DEXAMETHASONE INCREASES HEPATOTOXICITY OF MTX IN CHILDREN WITH BRAIN-TUMORS, Anticancer research, 18(4B), 1998, pp. 2895-2899
Authors:
FRANZIUS C
SCIUK J
ERNST R
JURGENS H
SCHOBER O
Citation: C. Franzius et al., MONITORING CHEMOTHERAPY RESPONSE IN PRIMARY BONE-TUMORS USING F-18 FDG-PET IN COMPARISON TO TC-99M-MDP BONE-SCINTIGRAPHY, The Journal of nuclear medicine, 39(5), 1998, pp. 445-445
Authors:
KLETA R
WAGNER A
JURGENS H
Citation: R. Kleta et al., RECURRENCE OF SIADH AFTER A HIGH-DOSE REGIMEN OF THIOTEPA, CARBOPLATIN, AND ETOPOSIDE PHOSPHATE, Medical and pediatric oncology, 31(2), 1998, pp. 129-129
Authors:
KLETA R
SCHLEEF J
JURGENS H
Citation: R. Kleta et al., LETTER TO THE EDITOR - TISSUE-PLASMINOGEN ACTIVATOR AND OBSTRUCTED CENTRAL VENOUS CATHETERS, Medical and pediatric oncology, 30(6), 1998, pp. 376-376
Authors:
KLINGEBIEL T
PERTL U
HESS CF
JURGENS H
KOSCIELNIAK E
POTTER R
VANHEEKROMANOWSKI R
ROSSI R
SCHOTT C
SPAAR HJ
WILLNOW U
TREUNER J
Citation: T. Klingebiel et al., TREATMENT OF CHILDREN WITH RELAPSED SOFT-TISSUE SARCOMA - REPORT OF THE GERMAN CESS CWS REZ-91 TRIAL/, Medical and pediatric oncology, 30(5), 1998, pp. 269-275
Authors:
ROSSIG C
RITTER J
JURGENS H
BOOS J
Citation: C. Rossig et al., PROPHYLAXIS AND THERAPY FOR VARICELLA-ZOS TER VIRUS-INFECTIONS IN IMMUNOSUPPRESSED CHILDREN, Monatsschrift fur Kinderheilkunde, 146(3), 1998, pp. 200-207
Authors:
DOCKHORNDWORNICZAK B
BRINKSCHMIDT C
POREMBA C
SCHAFER KL
JURGENS H
BOCKER W
Citation: B. Dockhorndworniczak et al., CHROMOSOME-11 ALTERATIONS - A COMMON MECHANISM IN TUMORIGENESIS OF RHABDOMYOSARCOMAS, Laboratory investigation, 78(1), 1998, pp. 27-27
Authors:
KARTHAUS M
CARRATALA J
JURGENS H
GANSER A
Citation: M. Karthaus et al., NEW STRATEGIES IN THE TREATMENT OF INFECTIOUS COMPLICATIONS IN HEMATOLOGY AND ONCOLOGY - IS THERE A ROLE FOR OUTPATIENT ANTIBIOTIC-TREATMENT OF FEBRILE NEUTROPENIA, Chemotherapy, 44(6), 1998, pp. 427-435
Authors:
KARTHAUS M
WOLF HH
KAMPFE D
EGERER G
RITTER J
PETERS G
SUDHOFF T
FRANKE A
HEIL G
KULLMANN KH
JURGENS H
Citation: M. Karthaus et al., CEFTRIAXONE MONOTHERAPY IN THE TREATMENT OF LOW-RISK FEBRILE NEUTROPENIA, Chemotherapy, 44(5), 1998, pp. 343-354